ArticleNature. Mental health2025
The network-based underpinnings of persisting symptoms after concussion: a multimodal neuroimaging meta-analysis.
Article in Nature. Mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Concussion: A Comprehensive Review of Current Evidence.Current reviews in musculoskeletal medicine · 2026Review
- Investigating the methodological foundation of lesion network mapping.Nature neuroscience · 2026Article
- Traumatic brain injury and neurological stealth syndromes.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persisting symptoms after concussion (PSaC) represent a complex and poorly understood neuropsychiatric phenomenon with limited treatment options. Neural network dysfunction has been associated with PSaC, and neuromodulation, particularly repetitive transcranial magnetic stimulation, may be a promising intervention. However, neuroimaging findings have been inconsistent, limiting understanding of underlying network dysfunction. We aimed to identify a core neural network associated with PSaC and explore whether this network could yield candidate cortical targets for neuromodulation at the individual level. We hypothesized that differences in network disruption would be evident between individuals with high versus low symptom burden in PSaC. Here we show that a convergent multi-analytic approach combining symptom-activation maps generated from existing fMRI datasets, systematic review of resting-state fMRI studies of PSaC, and network-based meta-analysis of coordinates derived from these studies co-localize to the salience network in high symptom burden PSaC. Using Human Connectome Project data, we mapped this network to cortical regions that could serve as individualized targets for neuromodulation. This aligns with current clinical models of PSaC and may present a new direction for network-based therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.